CastleArk Alternatives’s SI-BONE Inc SIBN Stock Holding History

CastleArk Alternatives’s Portfolio SIBN Stock Details SIBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-54,227	Closed	-$1.16M	–	243
2021 Q3	$1.16M	Buy	+54,227	New	+$1.37M	0.04%	216

Other funds holding SIBN

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

CastleArk Alternatives's SIBN Position: Q4 2021 in Review

CastleArk Alternatives sold out of SI-BONE Inc (SIBN) in Q4 2021, closing a stake of 54,227 shares — an estimated $1.16M sold.

CastleArk Alternatives first reported a position in SIBN in Q3 2021 and held it in 1 quarter. The position peaked at $1.16M in Q3 2021. 115 funds tracked by Wall St. Rank hold SIBN as of Q4 2021.

CastleArk Alternatives reported no remaining SI-BONE Inc position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 54,227 SI-BONE Inc shares in Q4 2021, an estimated $1.16M.
CastleArk Alternatives first reported a position in SI-BONE Inc in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's SI-BONE Inc position peaked at $1.16M in Q3 2021.
115 funds tracked by Wall St. Rank held SI-BONE Inc as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.